Targeting microRNA-145-mediated progressive phenotypes of early bladder cancer in a molecularly defined in vivo model

A progressive subclass of early-stage non-muscle-invasive bladder cancer (NMIBC) frequently recurs and progress into invasive carcinoma, thus decreasing the overall survival rate of NMIBC. However, therapeutic development for progressive NMIBC has been challenging due to the lack of molecularly vali...

Descripción completa

Detalles Bibliográficos
Autores principales: Heishima, Kazuki, Sugito, Nobuhiko, Abe, Chikara, Hirata, Akihiro, Sakai, Hiroki, Akao, Yukihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505924/
https://www.ncbi.nlm.nih.gov/pubmed/37727442
http://dx.doi.org/10.1016/j.omtn.2023.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505924/
https://www.ncbi.nlm.nih.gov/pubmed/37727442
http://dx.doi.org/10.1016/j.omtn.2023.06.009

Ejemplares similares